Back to discover
Disease

Chromosomal Instability

Active therapeutic pipelineEmerging researchRising momentum
6
Publications
2
Clinical trials
4
Related conditions
2024
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Executive briefingUpdating summary…Momentum: Low
Key developments
  • 2 clinical trials with recent milestones.
  • 1 industry development reported.
Major developments

Clinical trials

1 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme
2
All trials
2
Active
0
Late-stage
0
Completed
Recruiting

Research activity

6 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Publications over time
20202024
Major themes8
  • Carcinoma, Renal Cell1
  • Colorectal Neoplasms1
  • Disease Progression1
  • Epstein-Barr Virus Infections1
  • Evolution, Molecular1
  • Gene Expression Regulation, Neoplastic1
  • Genetic Predisposition to Disease1
  • Genome, Human1
Leading journals4
  • International journal of molecular sciences2
  • Nature2
  • Cancer discovery1
  • Nature cancer1
Leading researchers8
  • Bakhoum SF2
  • Litchfield K2
  • Tomlinson IPM2
  • Turajlic S2
  • Al Moustafa AE1
  • Alexandrov LB1
  • Allouch A1
  • Andre F1
Affiliations (unnormalised)6
  • Memorial Sloan Kettering Cancer Center3
  • The Francis Crick Institute2
  • University College London Cancer Institute2
  • Aarhus University Hospital1
  • Berlin Institute for Medical Systems Biology1
  • Big Data Institute1

Related conditions

4 matches

Diseases frequently studied alongside this one. Number shows shared papers.

Disease profile

A grounded synthesis of the condition — overview, causes, mechanism, risk factors and current standard of care.

Overview

Chromosomal instability is an increased tendency for cells to acquire chromosome abnormalities when the processes that replicate, repair, or segregate chromosomes are dysfunctional. It is described in cancer literature as a feature of tumors with elevated rates of chromosomal instability and is associated with aneuploidies and structural chromosomal rearrangements. Micronuclei are a recognized manifestation of this state and are seen in human cancers.

Causes

The supplied material does not identify a single established cause. It indicates that chromosomal instability arises when chromosome replication, repair, or segregation processes are dysfunctional. In gastric cancer, the causes are described as still being under discussion.

Pathophysiology

The core mechanism is failure of chromosome maintenance, leading to chromosome aberrations, mis-segregation, aneuploidy, and structural rearrangements. Chromosome-containing micronuclei can form from mis-segregated chromosomes and are linked to elevated chromosomal instability. The literature also connects chromosomal instability with DNA copy number variations and loss of heterozygosity.

Risk factors

The supplied grounding does not support general risk factors for chromosomal instability as a standalone disease entity. In cancer contexts, it is associated with tumors that show chromosome mis-segregation and micronuclei formation, but no broader risk factors are provided.

Current standard of care

No standard treatment for chromosomal instability itself is supported in the supplied material. The reviews describe it as a tumor feature or subtype relevant to cancer progression, biomarker development, and therapeutic targeting, rather than a condition with a direct disease-specific treatment. In the cited cancer contexts, management is discussed at the level of cancer therapies and molecular targeting, but no specific standard-of-care modality for chromosomal instability is established here.

AI-generated summary grounded in MeSH and 3 peer-reviewed sources. Informational only — not medical advice. Generated 2026-07-07.

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

An increased tendency to acquire CHROMOSOME ABERRATIONS when various processes involved in chromosome replication, repair, or segregation are dysfunctional.

References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.